Association of perioperative statin use with mortality and morbidity after major noncardiac surgery

JAMA Internal Medicine

Volumn 177, Issue 2, 2017, Pages 231-242

  London, Martin J ^a,b   Schwartz, Gregory G ^c   Hur, Kwan ^c   Henderson, William G ^d,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF COLORADO   (United States)

^e Food Science and Human Nutrition   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN;

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; CENTRAL NERVOUS SYSTEM; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; COMA; DEEP VEIN THROMBOSIS; DRUG EXPOSURE; DRUG USE; ELECTIVE SURGERY; EMERGENCY SURGERY; FEMALE; FOLLOW UP; GENERAL SURGERY; GRAFT FAILURE; HEART ARREST; HEART INFARCTION; HEART SURGERY; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; KIDNEY FAILURE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MAJOR SURGERY; MALE; MORBIDITY; NEUROSURGERY; OBSERVATIONAL STUDY; ORTHOPEDIC SURGERY; OTORHINOLARYNGOLOGY; OUTPATIENT; PERIOPERATIVE PERIOD; PNEUMONIA; POSTOPERATIVE COMPLICATION; PRESCRIPTION; PRIORITY JOURNAL; Q WAVE; RETROSPECTIVE STUDY; RISK FACTOR; RISK REDUCTION; SEPSIS; SURGICAL MORTALITY; THORAX SURGERY; THROMBOPHLEBITIS; TOTAL QUALITY MANAGEMENT; UROLOGIC SURGERY; VASCULAR SURGERY; VETERAN; WEANING; CAUSE OF DEATH; MORTALITY; POSTOPERATIVE COMPLICATIONS; PROCEDURES; PROPENSITY SCORE; RISK ASSESSMENT; SELECTION BIAS; SURGERY; TRENDS;

AGED; CAUSE OF DEATH; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MORBIDITY; MORTALITY; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; PROPENSITY SCORE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SELECTION BIAS; SURGICAL PROCEDURES, OPERATIVE; VETERANS;

EID: 85014547174     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamainternmed.2016.8005     Document Type: Article

References (50)

1. Kantor ED, Rehm CD, Haas JS, Chan AT, Giovannucci EL. Trends in prescription drug use among adults in the United States from 1999-2012. JAMA. 2015;314(17):1818-1831.
2. Stone NJ, Robinson JG, Lichtenstein AH, et al; American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129(25) (suppl 2):S1-S45.
3. Pasternak RC, Smith SC Jr, Bairey-Merz CN, Grundy SM, Cleeman JI, Lenfant C; American College of Cardiology; American Heart Association; National Heart, Lung and Blood Institute. ACC/AHA/NHLBI clinical advisory on the use and safety of statins. Circulation. 2002;106(8):1024-1028.
4. Leung A, Schaefer EW, TempelhofMW, Stone NJ. Emphasizing statin safety in the hospitalized patient: a review. Am J Med. 2012;125(9):845-853.
5. deWaal BA, Buise MP, van Zundert AA. Perioperative statin therapy in patients at high risk for cardiovascular morbidity undergoing surgery: a review. Br J Anaesth. 2015;114(1):44-52.
6. Kuhn EW, Slottosch I,Wahlers T, Liakopoulos OJ. Preoperative statin therapy for patients undergoing cardiac surgery. Cochrane Database Syst Rev. 2015; 8(8):CD008493.
7. Sanders RD, Nicholson A, Lewis SR, Smith AF, Alderson P. Perioperative statin therapy for improving outcomes during and after noncardiac vascular surgery. Cochrane Database Syst Rev. 2013;7(7):CD009971.
8. Antoniou GA, Hajibandeh S, Hajibandeh S, Vallabhaneni SR, Brennan JA, Torella F. Meta-analysis of the effects of statins on perioperative outcomes in vascular and endovascular surgery. J Vasc Surg. 2015;61(2):519-532.e1.
9. Fleisher LA, Fleischmann KE, Auerbach AD, et al. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;130(24): 2215-2245.
10. Kristensen SD, Knuuti J, Saraste A, et al; Authors/Task Force Members. 2014 ESC/ESA guidelines on non-cardiac surgery: cardiovascular assessment and management: the Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). Eur Heart J. 2014;35(35): 2383-2431.
11. Nowbar AN, Cole GD, Shun-Shin MJ, Finegold JA, Francis DP. International RCT-based guidelines for use of preoperative stress testing and perioperative ?-blockers and statins in non-cardiac surgery. Int J Cardiol. 2014;172(1):138-143.
12. Lindenauer PK, Pekow P,Wang K, Gutierrez B, Benjamin EM. Lipid-lowering therapy and in-hospital mortality following major noncardiac surgery. JAMA. 2004;291(17):2092-2099.
13. Iannuzzi JC, Rickles AS, Kelly KN, et al. Perioperative pleiotropic statin effects in general surgery. Surgery. 2014;155(3):398-407.
14. Berwanger O, Le Manach Y, Suzumura EA, et al; VISION Investigators. Association between pre-operative statin use and major cardiovascular complications among patients undergoing non-cardiac surgery: the VISION study. Eur Heart J. 2016;37(2):177-185.
15. London MJ, Hur K, Schwartz GG, Henderson WG. Association of perioperative ?-blockade with mortality and cardiovascular morbidity following major noncardiac surgery. JAMA. 2013;309(16): 1704-1713.
16. Maynard C, Chapko MK. Data resources in the Department of Veterans Affairs. Diabetes Care. 2004;27(suppl 2):B22-B26.
17. Lee TH, Marcantonio ER, Mangione CM, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation. 1999;100(10): 1043-1049.
18. Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70:41-55.
19. WuWC, Schifftner TL, HendersonWG, et al. Preoperative hematocrit levels and postoperative outcomes in older patients undergoing noncardiac surgery. JAMA. 2007;297(22):2481-2488.
20. Hamilton BH, Ko CY, Richards K, Hall BL. Missing data in the American College of Surgeons National Surgical Quality Improvement Program are not missing at random: implications and potential impact on quality assessments. J AmColl Surg. 2010;210(2):125-139.e2.
21. Suissa S. Immortal time bias in pharmaco-epidemiology. Am J Epidemiol. 2008;167 (4):492-499.
22. Austin PC. Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies. Pharm Stat. 2011;10(2): 150-161.
23. Austin PC. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med. 2009;28(25):3083-3107.
24. Agresti A, Min Y. Effects and non-effects of paired identical observations in comparing proportions with binary matched-pairs data. Stat Med. 2004;23(1):65-75.
25. Hindler K, Shaw AD, Samuels J, Fulton S, Collard CD, Riedel B. Improved postoperative outcomes associated with preoperative statin therapy. Anesthesiology. 2006;105(6):1260-1272.
26. Winchester DE,Wen X, Xie L, Bavry AA. Evidence of pre-procedural statin therapy a meta-analysis of randomized trials. J AmColl Cardiol. 2010;56(14):1099-1109.
27. SchoutenO, Boersma E, Hoeks SE, et al; Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. Fluvastatin and perioperative events in patients undergoing vascular surgery.NEngl JMed. 2009;361(10):980-989.
28. Devereaux PJ, Chan MT, Alonso-Coello P, et al; Vascular Events In Noncardiac Surgery Patients Cohort Evaluation (VISION) Study Investigators. Association between postoperative troponin levels and 30-day mortality among patients undergoing noncardiac surgery. JAMA. 2012;307(21):2295-2304.
29. Brunelli SM,Waikar SS, Bateman BT, et al. Preoperative statin use and postoperative acute kidney injury. Am J Med. 2012;125(12):1195-1204.e3.
30. Le Manach Y, Ibanez Esteves C, Bertrand M, et al. Impact of preoperative statin therapy on adverse postoperative outcomes in patients undergoing vascular surgery. Anesthesiology. 2011; 114(1):98-104.
31. Molnar AO, Coca SG, Devereaux PJ, et al. Statin use associates with a lower incidence of acute kidney injury after major elective surgery. J AmSoc Nephrol. 2011;22(5):939-946.
32. Argalious MY, Dalton JE, Sreenivasalu T, O'Hara J, Sessler Di. The association of preoperative statin use and acute kidney injury after noncardiac surgery. Anesth Analg. 2013;117(4):916-923.
33. Yadav H, Lingineni RK, Slivinski EJ, et al. Preoperative statin administration does not protect against early postoperative acute respiratory distress syndrome: a retrospective cohort study. Anesth Analg. 2014;119(4):891-898.
34. Baigent C, Blackwell L, Emberson J, et al; Cholesterol Treatment Trialists' (CTT) Collaboration. Efficacy and safety of more intensive lowering of LDL cholesterol: ameta-analysis of data from 170,000 participants in 26 randomised trials. Lancet. 2010;376(9753):1670-1681.
35. Xia J, Qu Y, Shen H, Liu X. Patients with stable coronary artery disease receiving chronic statin treatment who are undergoing noncardiac emergency surgery benefit from acute atorvastatin reload. Cardiology. 2014;128(3):285-292.
36. Bin C, JunshengM, Jianqun Z, Ping B. Meta-analysis of medium and long-term efficacy of loading statins after coronary artery bypass grafting. Ann Thorac Surg. 2016;101(3):990-995.
37. Benjo AM, El-Hayek GE, Messerli F, et al. High dose statin loading prior to percutaneous coronary intervention decreases cardiovascular events: ameta-analysis of randomized controlled trials. Catheter Cardiovasc Interv. 2015;85(1):53-60.
38. Billings FT IV, Hendricks PA, Schildcrout JS, et al. High-dose perioperative atorvastatin and acute kidney injury following cardiac surgery: a randomized clinical Trial. JAMA. 2016;315(9):877-888.
39. Zheng Z, Jayaram R, Jiang L, et al. Perioperative rosuvastatin in cardiac surgery. N Engl J Med. 2016;374(18):1744-1753.
40. McCandless LC. Statin use and fracture risk: can we quantify the healthy-user effect? Epidemiology. 2013;24(5):743-752.
41. van Rein N, Cannegieter SC, le Cessie S, et al. Statins and risk of bleeding: an analysis to evaluate possible bias due to prevalent users and healthy user aspects. Am J Epidemiol. 2016;183(10):930-936.
42. RayWA. Evaluating medication effects outside of clinical trials: new-user designs. Am J Epidemiol. 2003;158(9):915-920.
43. Bansilal S, Castellano JM, Garrido E, et al. Assessing the impact of medication adherence on long-term cardiovascular outcomes. J AmColl Cardiol. 2016;68(8):789-801.
44. Herttua K, Martikainen P, Batty GD, Kivimäki M. Poor adherence to statin and antihypertensive therapies as risk factors for fatal stroke. J AmColl Cardiol. 2016;67(13):1507-1515.
45. Aarnio E, Martikainen J, Winn AN, Huupponen R, Vahtera J, Korhonen MJ. Socioeconomic inequalities in statin adherence under universal coverage: does sex matter [published online October 18, 2016]? Circ Cardiovasc Qual Outcomes. doi:10.1161/CIRCOUTCOMES.116.002728
46. Jörntén-Karlsson M, Pintat S, Molloy-Bland M, Berg S, AhlqvistM. Patient-centered interventions to improve adherence to statins: a narrative synthesis of systematically identified studies. Drugs. 2016;76(15):1447-1465.
47. Vinogradova Y, Coupland C, Brindle P, Hippisley-Cox J. Discontinuation and restarting in patients on statin treatment: prospective open cohort study using a primary care database. BMJ. 2016;353:i3305.
48. Le Manach Y, Godet G, Coriat P, et al. The impact of postoperative discontinuation or continuation of chronic statin therapy on cardiac outcome after major vascular surgery. Anesth Analg. 2007;104(6):1326-1333.
49. Amar D, Park B, Zhang H, et al. Beneficial effects of perioperative statins for major pulmonary resection. J Thorac Cardiovasc Surg. 2015;149(6): 1532-1538.
50. Baigent C, Keech A, Kearney PM, et al; Cholesterol Treatment Trialists' (CTT) Collaborators. Efficacy and safety of cholesterol-lowering treatment: prospectivemeta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet. 2005;366(9493):1267-1278.